Skip to content

PRESTIGE LP Cervical Disc System (1 level) Regulated PMS

PRESTIGE LP Cervical Disc System (1 level) Regulated PMS - PRESTIGE LP Cervical Disc System (1 level) Regulated PMS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030267
Enrollment
67
Registered
2017-12-14
Start date
2017-12-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Single-level radiculopathy or myelopathy involving herniated disk or osteophyte formation

Interventions

None listed

Sponsors

Medtronic Sofamor Danek, Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients unresponsive to non-operative therapy of at least three months with single-level radiculopathy or myelopathy involving herniated disc or osteophyte formation observed under imaging tests.

Exclusion criteria

Exclusion criteria: 1) Patients allergic to metals 2) Patients in the process of active infection, or with a serious risk of infection such as an immunodeficiency 3) Patients with a disease that involves severe bone fragility, (or with a cervical vertebra so fragile as to experience difficulty in receiving an implant due to diseases such as severe osteoporosis, osteomalacia, Paget's disease of bone, renal osteodystrophy, Ehlers-Danlos Syndrome, osteogenesis imperfecta, etc.) 4) Patients with notable cervical instability under the lateral images of ante-/retro-flexion 5) Patients with either of the following severe cervical diseases: (1) Bridging osteophyte formation observed at the treated level without maintaining mobility (2) Significantly-narrowing intervertebral height observed at the treated level 6) Patients with a severe facet joint arthrosis at the treated level 7) Patients with a significant lesion or deformity of vertebral body 8) Patients presenting obvious abnormality in cervical alignment (e.g. local kyphosis) 9) Patients presenting an obvious cervical spinal canal stenosis across multiple levels 10) Patients with a trauma involving cervical bone fracture, ligament injury, etc. 11) Patients presenting obvious involuntary movement at the head and neck area

Design outcomes

Primary

MeasureTime frame
Among adverse events/deficiencies, secondary surgeries and implant-related events (subsidence, migration, etc.) (1) Secondary surgery Surgical procedures at the treated level, including revision, removal, supplemental fixation and reoperation (2) Implant-related event Subsidence of implant, fall of implant, migration of implant, or other implant-related event

Countries

Japan

Contacts

Public ContactShigeaki Sakurai

Medtronic Japan Co., Ltd. Japan Clinical and Medical Affairs

sakurs2@medtronic.com03-6776-1406

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026